Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Imaging: Use of MRI as an outcome measure in clinical trials in RA.

van der Helm-van Mil AH.

Nat Rev Rheumatol. 2012 Nov;8(11):643-4. doi: 10.1038/nrrheum.2012.182. Epub 2012 Oct 16. No abstract available.

PMID:
23070641
2.

How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis?

van der Helm-van Mil AH, Knevel R, van der Heijde D, Huizinga TW.

Rheumatology (Oxford). 2010 Aug;49(8):1429-35. doi: 10.1093/rheumatology/keq013. Epub 2010 Mar 4. Review.

3.

Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis.

van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2007 Jun;56(6):1728-35. Review. No abstract available.

4.

Association of tumor necrosis factor alpha polymorphism and radiographic progression in rheumatoid arthritis: comment on the article by Khanna et al.

van der Helm-van Mil AH, Kurreeman FA, Toes RE, Huizinga TW.

Arthritis Rheum. 2007 Mar;56(3):1032-3; author reply1033-4. No abstract available.

5.

A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions.

van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW.

Arthritis Rheum. 2007 Feb;56(2):433-40.

6.

The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.

van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2007 Feb;56(2):425-32.

7.

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity.

van der Helm-van Mil AH, Breedveld FC, Huizinga TW.

Arthritis Res Ther. 2006;8(4):216. Review.

8.

Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients.

van der Helm-van Mil AH, Kern M, Gregersen PK, Huizinga TW.

Arthritis Rheum. 2006 Jun;54(6):2028-30. No abstract available.

9.
10.

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.

Arthritis Res Ther. 2005;7(5):R949-58. Epub 2005 Jun 14.

11.

Understanding the genetic contribution to rheumatoid arthritis.

van der Helm-van Mil AH, Wesoly JZ, Huizinga TW.

Curr Opin Rheumatol. 2005 May;17(3):299-304. Review.

PMID:
15838240
12.

Hypernatremia from a hunger strike as a cause of osmotic myelinolysis.

van der Helm-van Mil AH, van Vugt JP, Lammers GJ, Harinck HI.

Neurology. 2005 Feb 8;64(3):574-5. No abstract available.

PMID:
15699405
13.

No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes.

van der Helm-van Mil AH, Dieudé P, Schonkeren JJ, Cornélis F, Huizinga TW.

Rheumatology (Oxford). 2004 Oct;43(10):1232-4. Epub 2004 Jul 13.

14.

No influence of melatonin on cerebral blood flow in humans.

van der Helm-van Mil AH, van Someren EJ, van den Boom R, van Buchem MA, de Craen AJ, Blauw GJ.

J Clin Endocrinol Metab. 2003 Dec;88(12):5989-94.

PMID:
14671201
15.

Immunoglobulin A multiple myeloma presenting with Henoch-Schönlein purpura associated with reduced sialylation of IgA1.

Van Der Helm-Van Mil AH, Smith AC, Pouria S, Tarelli E, Brunskill NJ, Eikenboom HC.

Br J Haematol. 2003 Sep;122(6):915-7.

PMID:
12956761
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk